Relugolix Enrolling by Invitation Phase 3 Trials for Heavy Menstrual Bleeding / Uterine Leiomyomas Treatment

IndicationsStatusPurposePhase
Enrolling by InvitationTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT03751124Study of Relugolix With Estradiol and Norethindrone Acetate in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids